Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lycke

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1991
Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptidesP Horal, W W Hall, B Svennerholm, et al.
European Journal of Neurology|February 15, 2019
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosisM Boremalm, A Juto, M Axelsson, et al.
Acta Neurologica Scandinavica|June 15, 2013
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosisJ Kuhle, C Malmeström, M Axelsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosisO Andersen, J Lycke, P O Tollesson, et al.
Neurology|October 1, 1996
Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosisO Andersen, J Lycke, P O Tollesson, et al.
Multiple Sclerosis and Related Disorders|February 2, 2025
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life useM Johnsson, K Eriksson, I Rosenstein, et al.
Neurotrauma Reports|February 3, 2022
Normalized Brain Tissue-Level Evaluation of Volumetric Changes of Youth Athletes Participating in Collision SportsPratik Kashyap, Trey E Shenk, Diana O Svaldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2024
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center studyM Johnsson, Y T Stenberg, H H Farman, et al.
Scientific Reports|January 19, 2024
Longitudinal changes in resting state fMRI brain self-similarity of asymptomatic high school American football athletesBradley Fitzgerald, Sumra Bari, Nicole Vike, et al.
Neurology|January 10, 2002
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MSE Bech, J Lycke, P Gadeberg, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1991
Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptidesP Horal, W W Hall, B Svennerholm, et al.
European Journal of Neurology|February 15, 2019
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosisM Boremalm, A Juto, M Axelsson, et al.
Acta Neurologica Scandinavica|June 15, 2013
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosisJ Kuhle, C Malmeström, M Axelsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosisO Andersen, J Lycke, P O Tollesson, et al.
Neurology|October 1, 1996
Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosisO Andersen, J Lycke, P O Tollesson, et al.
Multiple Sclerosis and Related Disorders|February 2, 2025
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life useM Johnsson, K Eriksson, I Rosenstein, et al.
Neurotrauma Reports|February 3, 2022
Normalized Brain Tissue-Level Evaluation of Volumetric Changes of Youth Athletes Participating in Collision SportsPratik Kashyap, Trey E Shenk, Diana O Svaldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2024
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center studyM Johnsson, Y T Stenberg, H H Farman, et al.
Scientific Reports|January 19, 2024
Longitudinal changes in resting state fMRI brain self-similarity of asymptomatic high school American football athletesBradley Fitzgerald, Sumra Bari, Nicole Vike, et al.
Neurology|January 10, 2002
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MSE Bech, J Lycke, P Gadeberg, et al.
Pageof 5